OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Nephrology and Hypertension is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	41
Dual organ transplantation: Pancreas and Liver in the kidney axis	40
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	28
Editorial introductions	27
Maximizing opportunities for kidney transplantation in older adults	24
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	22
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	20
Interferon gamma in the pathogenesis of hypertension − recent insights	20
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	18
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	18
The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated	18
Evolution in the targets for blood pressure treatment	17
The impact of conflicts on patients with chronic kidney disease	17
Editorial introduction	17
Prediction models for earlier stages of chronic kidney disease	16
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	16
International equity in access to home dialysis	16
Renal denervation for the treatment of hypertension and kidney disease	14
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	14
Modern indications for referral for kidney and pancreas transplantation	13
Bringing the end-stage kidney disease life plan home	13
Staying home when peritoneal dialysis ends: the integrated home dialysis approach	12
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	12
The race coefficient in glomerular filtration rate-estimating equations and its removal	12
Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	12

Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	12
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	12
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	11
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	11
Editorial: One size does not fit all: moving toward individualized therapy	11
Built environment and chronic kidney disease: current state and future directions	11
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	11
Plant-based diets for kidney disease prevention and treatment	11
Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	11
Bringing medical education “home”: the university health network and St. Michael's hospital home dialysis fellowship	10
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	10
Complement detection in kidney biopsies – utility and challenges	10
Understanding renal phosphate handling: unfinished business	10
Editorial: Advancements in the management of kidney disease and electrolyte derangements	9
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	9
Combination therapy with kidney protective therapies: optimizing the benefits?	9
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	9
Lipocalin-2: a novel link between the injured kidney and the bone	9
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	9
A guide for program development of environmentally sustainable kidney care	9
Editorial introductions	9
Climate change and kidney stones	8
When the earth shakes unexpectedly: impact on nephrology services and patients	8
The current therapeutic approach for anaemia after kidney transplant	8
Editorial introductions	8
Cancer drugs and acute kidney injury: new therapies and new challenges	8
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	8
Deep learning applications for kidney histology analysis	8
A current update of the development of Chimeric Antigen Receptor T-cell therapy and kidney disease	8
Automation and innovation in home hemodialysis machines	8
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	8
HIV-associated kidney disease: the changing spectrum and treatment priorities	8
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	7
Recent advances in treatment options for kidney disease	7
Editorial introductions	7
Prospects for gene therapy in polycystic kidney disease	7
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	7
New and old approaches to nutritional management of acute and chronic glomerulonephritis	7
Editorial introductions	7
Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	7
Impact of intensive blood pressure control on kidney outcomes	7
Evolving thresholds for the diagnosis of acute T cell mediated rejection	7
Editorial introduction	7
C3 glomerulopathy: advancements in diagnostics and therapeutics	7
New insights into renal calcium-sensing receptor activation	6
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	6
Building kidney organoids from pluripotent stem cells	6
Enhancing accuracy and adherence in blood pressure monitoring in living kidney donation: implementing technologies to overcome challenges	6
Sex differences in renal electrolyte transport	6
Screening for chronic kidney disease: change of perspective and novel developments	6

Contemporary risk prediction models in chronic kidney disease: when less is more	6
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	6
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	6
Renal osteodystrophy: something old, something new, something needed	6
Renal denervation: recent developments in clinical and preclinical research	6
Prevention of postoperative acute kidney injury: insights from recent clinical trials	6
Vaccination in kidney disease: what did we learn from COVID-19 pandemic	6
Novel agents for treating IgA nephropathy	5
The genetics of cystinuria – an update and critical reevaluation	5
Effects of aging on chronic kidney disease mineral and bone disorder	5
Staff-assisted peritoneal dialysis in the United States: from evidence to national adoption	5
Cystatin C should be routinely available for estimating kidney function	5
Chronic kidney disease and sex dimorphism	5
Novel approaches in antihypertensive pharmacotherapeutics	5
The changing trajectory of diabetic kidney disease	5
Targeting inflammation in hypertension	5
The role of calprotectin in vascular calcification	5
New therapeutics for primary hyperoxaluria type 1	5
Population health strategies for health equity in chronic kidney disease management	5
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	5
An update on corticosteroid treatment for IgA nephropathy	5
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?	5
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	5
Peritoneal dialysis and heart failure	5
WNK1 in the kidney	5
The potential of artificial intelligence-based applications in kidney pathology	5
Editorial introductions	5
Evolving indications and management patterns in heart – kidney transplantation	5
Fibroblast growth factor 23 as a risk factor for incident diabetes	5
Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era	5
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan	5
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	5
New guidelines and therapeutic updates for the management of lupus nephritis	5
Role of inwardly rectifying K+ channel 5.1 (Kir5.1) in the regulation of renal membrane transport	5